drugset / Trial / NCT01182766
New Treatment for Alcohol and Nicotine Dependence
Phase 2/3
Completed
236 enrolled
University of Virginia
M.D. Anderson Cancer Center · collabNational Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabUniversity of California, San Diego · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol and nicotine than individuals taking placebo.
Timeline
- Start
- 2011-11-01
- Primary completion
- 2017-10-06
- Completion
- 2017-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 125 mg | — |
| Subject | Topiramate | Small molecule | 250 mg | — |